Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Ancora Indonesia Resources Tbk. (OKAS) vs Tempo Scan Pacific Tbk. (TSPC)

Ancora Indonesia Resources Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Ancora Indonesia Resources Tbk. dan Tempo Scan Pacific Tbk.: Ancora Indonesia Resources Tbk. diperdagangkan di Rp122 (kapitalisasi pasar 272,95 M, volume 24 jam 22,27 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T, volume 24 jam 809,6 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 46,1× kapitalisasi pasar Ancora Indonesia Resources Tbk., dan Ancora Indonesia Resources Tbk. lebih aktif diperdagangkan (22,27 jt vs 809,6 rb). Mana yang lebih baik tergantung tujuan investasimu.

OKASTSPC
Kapitalisasi Pasar
272,95 M12,58 T
Volume
22,27 jt809,6 rb
Lot
222,66 rb8,1 rb
Perputaran
2,72 M2,26 M
Harga Rata-rata
122,212.786,16
Nilai Transaksi
2,72 M2,26 M
Harga Ekuilibrium Indikatif
1222.790
Volume Ekuilibrium Indikatif
1,86 rb1,63 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

OKAS
Lihat detail
TSPC
Lihat detail

Tentang Ancora Indonesia Resources Tbk.

PT Ancora Indonesia Resources Tbk (the Company) was establised on September 15, 2003. Based to the Extraordinary General Meeting of Shareholders,all shareholders approved the change of the Company's name from PT TD Resources Tbk to PT Ancora Indonesia Resources Tbk. This change of the Company's name was effective on December 3, 2008.

Selengkapnya di halaman OKAS

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC